ADB International Group (OTCMKTS:EQUR) and Neuronetics (NASDAQ:STIM) Critical Analysis

ADB International Group (OTCMKTS:EQUR) and Neuronetics (NASDAQ:STIM) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings.

Earnings and Valuation

This table compares ADB International Group and Neuronetics”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADB International Group	N/A	N/A	N/A	N/A	N/A
Neuronetics	$74.89 million	1.29	-$43.71 million	($0.82)	-1.72

ADB International Group has higher earnings, but lower revenue than Neuronetics.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for ADB International Group and Neuronetics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADB International Group	0	0	0	0	0.00
Neuronetics	1	0	1	0	2.00

Neuronetics has a consensus price target of $7.00, indicating a potential upside of 396.45%. Given Neuronetics’ stronger consensus rating and higher possible upside, analysts clearly believe Neuronetics is more favorable than ADB International Group.

Profitability

This table compares ADB International Group and Neuronetics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ADB International Group	N/A	N/A	N/A
Neuronetics	-33.88%	-131.15%	-31.26%

Institutional and Insider Ownership

53.6% of Neuronetics shares are owned by institutional investors. 79.6% of ADB International Group shares are owned by insiders. Comparatively, 8.7% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Neuronetics beats ADB International Group on 5 of the 9 factors compared between the two stocks.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

About Neuronetics

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.